These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36298691)

  • 21. In vitro growth and stability of recombinant rabies viruses designed for vaccination of wildlife.
    Dietzschold ML; Faber M; Mattis JA; Pak KY; Schnell MJ; Dietzschold B
    Vaccine; 2004 Dec; 23(4):518-24. PubMed ID: 15530701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The Infectious and Pathogenic Characteristics of Rabies Virus Strain CTNCEC25].
    Wang C; Luo S; Rong W; Liu Y; Li H; Zhu S; Tian H; Zhou W; Guo C
    Bing Du Xue Bao; 2015 Sep; 31(5):481-7. PubMed ID: 26738284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB).
    Knowles MK; Roberts D; Craig S; Sheen M; Nadin-Davis SA; Wandeler AI
    Vaccine; 2009 May; 27(20):2662-8. PubMed ID: 19428876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after
    Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2.
    Yang D; Li XF; Ye Q; Wang HJ; Deng YQ; Zhu SY; Zhang Y; Li SH; Qin CF
    Vaccine; 2014 May; 32(23):2675-81. PubMed ID: 24709585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Environmental distribution of certain modified live-virus vaccines with a high safety profile presents a low-risk, high-reward to control zoonotic diseases.
    Head JR; Vos A; Blanton J; Müller T; Chipman R; Pieracci EG; Cleaton J; Wallace R
    Sci Rep; 2019 May; 9(1):6783. PubMed ID: 31043646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
    Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
    Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Successful Elimination of Sylvatic Rabies Using Oral Vaccination of Foxes in Slovenia.
    Černe D; Hostnik P; Toplak I
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33806582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and neuroattenuation phenotypic characteristics and their stabilities of SA14-14-2 vaccine seed virus.
    Liu X; Zhao D; Jia L; Xu H; Na R; Ge Y; Liu S; Yu Y; Li Y
    Vaccine; 2018 Jul; 36(31):4650-4656. PubMed ID: 29954631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan.
    Ito H; Minamoto N; Watanabe T; Goto H; Rong LT; Sugiyama M; Kinjo T; Mannen K; Mifune K; Konobe T
    Microbiol Immunol; 1994; 38(6):479-82. PubMed ID: 7968680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
    Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
    J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife.
    Geue L; Schares S; Schnick C; Kliemt J; Beckert A; Freuling C; Conraths FJ; Hoffmann B; Zanoni R; Marston D; McElhinney L; Johnson N; Fooks AR; Tordo N; Müller T
    Vaccine; 2008 Jun; 26(26):3227-35. PubMed ID: 18485548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein.
    Nakagawa K; Nakagawa K; Omatsu T; Katayama Y; Oba M; Mitake H; Okada K; Yamaoka S; Takashima Y; Masatani T; Okadera K; Ito N; Mizutani T; Sugiyama M
    Vaccine; 2017 Oct; 35(42):5622-5628. PubMed ID: 28882441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a single-cycle rabies virus-based vaccine vector.
    Gomme EA; Faul EJ; Flomenberg P; McGettigan JP; Schnell MJ
    J Virol; 2010 Mar; 84(6):2820-31. PubMed ID: 20053743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine.
    Te Kamp V; Friedrichs V; Freuling CM; Vos A; Potratz M; Klein A; Zaeck LM; Eggerbauer E; Schuster P; Kaiser C; Ortmann S; Kretzschmar A; Bobe K; Knittler MR; Dorhoi A; Finke S; Müller T
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33466701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SAG-2 oral rabies vaccine.
    Schumacher CL; Coulon P; Lafay F; Bénéjean J; Aubert MF; Barrat J; Aubert A; Flamand A
    Onderstepoort J Vet Res; 1993 Dec; 60(4):459-62. PubMed ID: 7777336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus.
    Faber M; Faber ML; Li J; Preuss MA; Schnell MJ; Dietzschold B
    J Virol; 2007 Jul; 81(13):7041-7. PubMed ID: 17459937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuated Porcine Reproductive and Respiratory Syndrome Virus Regains Its Fatal Virulence by Serial Passaging in Pigs or Porcine Alveolar Macrophages To Increase Its Adaptation to Target Cells.
    Wang J; Zhang M; Cui X; Gao X; Sun W; Ge X; Zhang Y; Guo X; Han J; Zhou L; Yang H
    Microbiol Spectr; 2022 Dec; 10(6):e0308422. PubMed ID: 36219105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The present status of rabies vaccine development and clinical experience with rabies vaccine.
    Roumiantzeff M
    Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.